Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Annual Meeting | Aging and Dementia Posters

This program spans the entire conference
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Aging, Dementia, and Behavioral Neurology
0.00 credit
COVID-19

Program Materials Program Evaluations

Event Timeline
07:00 AM - 05:00 PM EDT Abstract 001 - Transcriptional deregulation in Parkinson’s disease by ATF4 transcription factor heterodimers
Radhika Jagannathan, MD
07:00 AM - 05:00 PM EDT Abstract 002 - Single-Cell Transcriptomics of the Microglial Complement Pathway in the Progression of Alzheimer’s Dementia
Takahisa Mikami, MD
07:00 AM - 05:00 PM EDT Abstract 003 - EARLY ENRICHMENT OF IMMUNOGLOBULINS IN TBI-INDUCED NEURODEGENERATION
Laura Gutierrez Quiceno, MD
07:00 AM - 05:00 PM EDT Abstract 004 - Sirtuin 6 is Reduced in Alzheimer’s Disease
Jiong Shi, MD, FÂé¶¹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 005 - X-linked Christianson Syndrome with Neurodegeneration and Atypical Parkinsonism in Female Carriers
Micaela R. Owens, DO
07:00 AM - 05:00 PM EDT Abstract 006 - Genotype-Phenotype Data of Rare ABCA7 Missense Mutations in Belgian Alzheimer’s Disease Patients
Elisabeth Hendrickx Van de Craen, MD
07:00 AM - 05:00 PM EDT Abstract 007 - In-Depth Phenotypic Description Of Pathogenic TBK1 Mutations; A Frequent Cause Of FTD And ALS In The Flanders-Belgian Population
Helena Gossye
07:00 AM - 05:00 PM EDT Abstract 008 - Extensive Genetic And Phenotypic Description Of MAPT p.R406W In The Flanders-Belgian Population
Helena Gossye
07:00 AM - 05:00 PM EDT Abstract 009 - Distinct Clinical Characteristics of PSEN1 P.Cys263phe Carriers Compared with Other PSEN1, PSEN2 and APP Carriers in a Flanders-Belgian AD Cohort
Elisabeth Hendrickx Van de Craen, MD
07:00 AM - 05:00 PM EDT Abstract 010 - The Relationship between Polygenic Risk Scores, Biomarker Status and Clinical Progression in Longitudinal Observational Cohorts.
Paula Daunt, PhD
07:00 AM - 05:00 PM EDT Abstract 011 - Pilot Study of a Randomized, Blinded, Placebo-Controlled Trial of Shunt Surgery in Idiopathic Normal Pressure Hydrocephalus
Michael A. Williams, MD, FÂé¶¹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 012 - Impact of pimavanserin on cognitive measures in patients with neurodegenerative disease (NDD): results from 4 placebo-controlled clinical studies
Clive G. Ballard, MD
07:00 AM - 05:00 PM EDT Abstract 013 - EMBARK: A Phase 3b, Open-Label, Single-Arm, Safety Study to Evaluate the Long-Term Safety and Efficacy of Aducanumab in Eligible Participants With Alzheimer’s Disease
Carmen Castrillo-Viguera
07:00 AM - 05:00 PM EDT Abstract 014 - Utilization of Home Nursing to Mitigate the Impact of COVID-19 on the Conduct of the Gantenerumab Graduate Trials
Alison Searle
07:00 AM - 05:00 PM EDT Abstract 015 - A Phase 1 Translational Pharmacology Study in Healthy Elderly Volunteers Evaluating the Safety, Tolerability, Pharmacokinetics, and CNS Activity of IW-6463, a CNS-penetrant, Soluble Guanylate Cyclase Stimulator
Chad E Glasser, PharmD
07:00 AM - 05:00 PM EDT Abstract 016 - Safety of hippocampal blood-brain barrier opening with focused ultrasound in Alzheimer's disease
Vibhor Krishna
07:00 AM - 05:00 PM EDT Abstract 017 - Baseline Characteristics for CLARITY-AD: A Phase 3 Placebo-controlled, Double-blind, Parallel-group, 18-month Stud Evaluating BAN2401 in Early Alzheimer's Disease
Shau Yu Lynch
07:00 AM - 05:00 PM EDT Abstract 018 - AL001 Blocks the Sortilin/PGRN Interaction and is a Potential Therapy for FTD-GRN
Robert Paul, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 019 - Results of the Presence Study Evaluating Mevidalen for the Treatment of Lewy Body Dementia (LBD)
Kevin M. Biglan, MD
07:00 AM - 05:00 PM EDT Abstract 020 - Abnormal Perception of Positive and Negative Stimuli in Preclinical Carriers of Mutations that cause Frontotemporal Dementia
Emily Hardy
07:00 AM - 05:00 PM EDT Abstract 021 - Increased Prevalence of Developmental Stuttering Across lvPPA, nfvPPA, and CBS Spectrum Degenerative Disorders
Zachary Miller, MD
07:00 AM - 05:00 PM EDT Abstract 022 - The Relationship Between the Frontotemporal Asymmetry and Neuropsychiatric Symptoms in bvFTD
Andrzej Sokolowski
07:00 AM - 05:00 PM EDT Abstract 023 - The Case for an Empathy Reserve: Corroborating the Effect of Occupation History on Symptom Age at Onset in Frontotemporal Dementia
Eleanor Palser, PhD
07:00 AM - 05:00 PM EDT Abstract 024 - Mathematical Modeling Reveals the Correlates of Cognitive Impairment Across the FTLD Spectrum
Camilla Cividini, MSc
07:00 AM - 05:00 PM EDT Abstract 025 - Co-Occurring PSP Pathology in Alzheimer’s Disease: A Case Series
David G. Coughlin, MD
07:00 AM - 05:00 PM EDT Abstract 026 - Retinal biomarkers as a predictor of cognitive performance in progranulin-haploinsufficient frontotemporal dementia
Frederike Cosima Oertel, MD
07:00 AM - 05:00 PM EDT Abstract 027 - Cross Sectional Analysis of Cognitive and Motor Dysfunction in Four-Repeat Tauopathies
Allison Snyder, MD
07:00 AM - 05:00 PM EDT Abstract 028 - Neural correlates of cognitive resilience differ between experiences of bilingualism and education: A cortical based morphometry study in Frontotemporal dementia
Faheem Arshad, Sr., MD
07:00 AM - 05:00 PM EDT Abstract 029 - On the Move: Changes in Motor Activity Level in Individuals with Frontotemporal Dementia
Carolina R. Silveira, PhD
07:00 AM - 05:00 PM EDT Abstract 030 - Race and Sex Differences in Risk of Dementia Diagnosis Among Older Veterans
07:00 AM - 05:00 PM EDT Abstract 031 - Hypertension is Associated with Increased Likelihood of Vascular and Decreased Likelihood of Degenerative Pathologies in Older Individuals
Hannah H. Nguyen, BS
07:00 AM - 05:00 PM EDT Abstract 032 - Characterization of Dietary Patterns, Cognitive Function and Mood in Diverse Populations of Cardiac Patients in the age of COVID-19
Thomas M. McNally
07:00 AM - 05:00 PM EDT Abstract 033 - Herpes labialis, Chlamydophila pneumoniae, Helicobacter pylori and cytomegalovirus infections and risk of dementia: The Framingham Heart Study
Eduardo M. Zilli, MD
07:00 AM - 05:00 PM EDT Abstract 034 - Statin Therapy and Risk of Alzheimer’s and Age-related Neurodegenerative Diseases
Georgina Torrandell Haro
07:00 AM - 05:00 PM EDT Abstract 035 - Association Between White Matter Disease and Cognitive Function is Independent of Alzheimer’s Disease Biomarker Profile
Sharon Lam
07:00 AM - 05:00 PM EDT Abstract 036 - Platelet Procoagulant Potential and Sex are Predictive of Cognitive Impairment at 12 Months after Lacunar Stroke
Sergio A. Ramirez-Salazar, MD
07:00 AM - 05:00 PM EDT Abstract 037 - Participants in The Systematic Multidomain Alzheimer’s Risk Reduction Trial (SMARRT): A Closer Look at Risk Factors by Sex and Race
Donna Tran
07:00 AM - 05:00 PM EDT Abstract 038 - The Genetic Crosstalk between Chronic Periodontitis and Alzheimer's Disease
Anthony Chukwunonso Ogbuehi, MSc
07:00 AM - 05:00 PM EDT Abstract 039 - Evaluating the causes of ED visits by patients with Alzheimer’s disease
Jean-Luc Rolland, MD
07:00 AM - 05:00 PM EDT Abstract 040 - Hypothalamic Atrophy in Alzheimer’s Disease
Alice Tao
07:00 AM - 05:00 PM EDT Abstract 041 - Amyloid, Tau and Metabolic Correlates of Cognition in Early and Late-Onset Alzheimer’s Disease
Jeremy Tanner, MD
07:00 AM - 05:00 PM EDT Abstract 042 - The Value of Multimodal Imaging with 123I-FP-CIT SPECT in Differential Diagnosis of Dementia with Lewy Bodies and Alzheimer’s Disease Dementia
Toji Miyagawa, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 043 - [11C]MK-6884 PET Tracer for M4 Muscarinic Cholinergic Receptors in Alzheimer’s Disease: Comparison with [18F]FDG PET
Belen Pascual, PhD
07:00 AM - 05:00 PM EDT Abstract 044 - Early differences in brain MRI segmented temporal gray matter volumes between cerebral arteriolosclerosis, Alzheimer disease, and mixed neuropathologies
Dixon Yang, MD
07:00 AM - 05:00 PM EDT Abstract 045 - FDG-PET Brain Metabolic Changes in A-/T-/N- Early- and Late-onset Cognitively Impaired Subjects
Paige E. Logan
07:00 AM - 05:00 PM EDT Abstract 046 - Is There Really a Relationship Between Hippocampal Atrophy and Cued Recall Deficits?
Louis-Charles Perrier-Ferland, MD
07:00 AM - 05:00 PM EDT Abstract 047 - Temporoparietal Cortical Thickness is Related to Cognitive and Physical Function in the Absence of Amyloid Pathology
Samuel N. Lockhart, PhD
07:00 AM - 05:00 PM EDT Abstract 048 - Atrophy of the Mammillary Bodies in Mild Cognitive Impairment
Yushan Pan
07:00 AM - 05:00 PM EDT Abstract 049 - Predictors of cerebral tauopathy in individuals with normal cognition and amnestic mild cognitive impairment (aMCI): results from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Ali Ezzati, MD
07:00 AM - 05:00 PM EDT Abstract 051 - Endothelial Progenitor Cells as a Protective Vascular Factor Against Memory Impairment in Older Adults with White Matter Hyperintensities
07:00 AM - 05:00 PM EDT Abstract 052 - Linking Amyloid to Cognition in the Pathogenesis and Treatment of Alzheimer’s Disease: Toward the Development of a “Quantitative A/T/N Model”
Norman Mazer
07:00 AM - 05:00 PM EDT Abstract 053 - Cerebrospinal Fluid Inflammatory Markers Predict Subsequent Cognitive Decline in Alzheimer’s Disease
Zeynep Demir, MD
07:00 AM - 05:00 PM EDT Abstract 054 - Stepwise Connectivity Paves the Way to Reveal Functional Network Vulnerability in Age-Related Neurodegenerative Disorders
Massimo Filippi, MD, FÂé¶¹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 055 - Task-Free Functional Networks Related to Emotion Processing
Veronica Castelnovo, MSc
07:00 AM - 05:00 PM EDT Abstract 056 - APOE-e4-mediated correlates of cerebrospinal fluid biomarkers of amyloidosis and neurodegeneration with cognition and functionality in dementia with Lewy bodies compared with Alzheimer’s dementia and cognitively healthy people
Fabricio F. De Oliveira, MD, PhD, BBA, MSc, FÂé¶¹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 057 - Normal and Abnormal Stage N3 Sleep in Patients with Cognitive Impairment and/or Neurodegenerative Diseases
Daniel Levendowski
07:00 AM - 05:00 PM EDT Abstract 058 - Increased monocyte/macrophage-driven pro-inflammatory mediators associated with cerebral amyloid angiopathy
Carson Finger
07:00 AM - 05:00 PM EDT Abstract 059 - Using a MoCA Score to Predict the Probability of Medical Decision-Making Capacity in Patients with Mild Cognitive Impairment (MCI) or Dementia
Noam Margalit
07:00 AM - 05:00 PM EDT Abstract 060 - Self-Administered Gerocognitive Examination (SAGE) for the Early Detection of Cognitive Impairment at Primary Care Provider (PCP) Visits
Douglas W. Scharre, MD, FÂé¶¹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 061 - A Disease Progression Model for Alzheimer’s Disease Predicts Longitudinal Trajectory of CDR-SB Score across different stages of the disease
Samira Jamalian
07:00 AM - 05:00 PM EDT Abstract 062 - A Linear Mixed Model of APOE e4 Associated Cognitive Decline in Alzheimer’s Disease
Xi Richard Chen
07:00 AM - 05:00 PM EDT Abstract 063 - Number and location of cerebral microbleeds (CMBs) are associated with global and domain-specific cognitive impairment
Ihtsham Haq, MD, FÂé¶¹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 064 - The effects of 12 week-smartphone based cognitive intervention with a chat-bot on white matter integrity in older adults with subjective memory complaint.
Sue Hyun Lee
07:00 AM - 05:00 PM EDT Abstract 065 - The Mobile Toolbox (MBT): A Completely Remote Platform for Cognitive Research
Sarah Pila
07:00 AM - 05:00 PM EDT Abstract 066 - Longitudinal Validity of UCSD Performance-Based Skills Assessment in Parkinson’s Disease
Tara Carlisle, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 067 - Determining In-Depth Information of Mild Cognitive Impairment: Clustering Using Unsupervised Machine Learning
Akarin Hiransuthikul, MD
07:00 AM - 05:00 PM EDT Abstract 068 - Recommendations for the Comprehensive Cognitive Neurology Telemedicine Examination
Dina S. Dass, MD
07:00 AM - 05:00 PM EDT Abstract 069 - Impact of APOE e4 Genotype on Initial Cognitive Symptoms Differs for Alzheimer’s and Lewy Body Neuropathology
Jagan Pillai, MD, PhD, FÂé¶¹´«Ã½Ó³»­
07:00 AM - 05:00 PM EDT Abstract 070 - Temporal onset of core features in Lewy body disease pathologic subtypes
Parichita Choudhury, MD
07:00 AM - 05:00 PM EDT Abstract 071 - Predictors of treatment-responsiveness in cerebral amyloid angiopathy with related inflammation
Alan Plotzker, MD
07:00 AM - 05:00 PM EDT Abstract 073 - Converging Longitudinal Patterns of Atrophy in Clinical Variants of Frontotemporal Lobar Degeneration
Edoardo G. Spinelli, MD
07:00 AM - 05:00 PM EDT Abstract 074 - Quantified Brain MR Volumes Contribute to Diagnostic Delineation of Behavioral Variant Frontotemporal Dementia from Early Onset Alzheimer's Disease
Somayeh Meysami, MD
07:00 AM - 05:00 PM EDT Abstract 075 - Non-Tremor Motor Dysfunction is Associated with Alzheimer's Disease Biomarkers in Lewy Body Dementias
Ian Walker, MD
07:00 AM - 05:00 PM EDT Abstract 076 - Cognitive Profile of Patients with Late-Onset Unexplained Epilepsy
Mallika Purandare
07:00 AM - 05:00 PM EDT Abstract 077 - Sex Differences for Alzheimer's Pathology Association with Dementia Severity in Lewy Body Dementia
Ece Bayram, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 078 - Non-REM Sleep with Hypertonia: A Potential Prodromal Biomarker for a-Synuclein-Related Neurodegenerative Disease
Daniel Levendowski
07:00 AM - 05:00 PM EDT Abstract 079 - Prevalence, risk factors, and impact of anxiety in the early stages of autopsy-confirmed Alzheimer’s disease: a retrospective study
Palak S. Patel, MD
07:00 AM - 05:00 PM EDT Abstract 080 - The Relationship Between Depressive Symptoms and Cognitive Function in Non-Demented Older Adults Across Different Alzheimer’s Disease Biomarker Profiles
Mariel Rubin-Norowitz
07:00 AM - 05:00 PM EDT Abstract 081 - Neuropsychiatric symptoms in early and late onset Alzheimer’s Disease
Neus Falgàs Martínez
07:00 AM - 05:00 PM EDT Abstract 082 - Impact of Insomnia-Medication Adherence in Alzheimer’s Disease Patients with Comorbid Depression
Zaina Qureshi
07:00 AM - 05:00 PM EDT Abstract 083 - The Scope and Burden of Agitation, Aggression and Related Symptoms (AARS) in Alzheimer's Patients
Rezaul Khandker
07:00 AM - 05:00 PM EDT Abstract 084 - Efficacy Difference of Antipsychotics in Alzheimer's Disease and Schizophrenia: Explained with Network Efficiency and Pathway Analysis Methods
Peihao Fan, MBBS
07:00 AM - 05:00 PM EDT Abstract 085 - The effect of goals of care conversations on advance care planning outcomes for persons with dementia
Heather Ma, MD
07:00 AM - 05:00 PM EDT Abstract 086 - Dementia research productivity and associations with socioeconomic factors and burden of disease in Southeast Asia
Marie Charmaine C. Sy, MD
07:00 AM - 05:00 PM EDT Abstract 087 - Virtual Training of CNAs as Essential Dementia-Care Personnel in the Age of COVID-19
Johanna S. Balas, BS
07:00 AM - 05:00 PM EDT Abstract 088 - Gaps in Dementia Training at the Medical Student Level: Slipping Through the Cracks
Aimen Vanood, MD
07:00 AM - 05:00 PM EDT Abstract 089 - The Association of Motoric Cognitive Risk with White Matter Hyperintensities and Microstructural Properties
Gabriela T. Gomez
07:00 AM - 05:00 PM EDT Abstract 090 - BDNF Mediates Improvement in Cognitive Performance after Computerized Cognitive Training
Casey Nicastri
07:00 AM - 05:00 PM EDT Abstract 091 - Prevalence of Surgical Procedures in Patients with Prion Disease
Christian C. Prusinski, DO
07:00 AM - 05:00 PM EDT Abstract 092 - Histopathological Assessment and Staging of Cerebrovascular Lesions Associated With Normal Brain Aging
Caroline Dallaire-Théroux, MD, PhD
07:00 AM - 05:00 PM EDT Abstract 093 - Characterization of a large single-site USA CADASIL cohort
Jennifer Zitser-Koren, MD
07:00 AM - 05:00 PM EDT Abstract 094 - Hereditary Spastic Paraplegia: Clinicogenetic Lessons from a Well-Defined Cohort
Ekhlas Assaedi, MD
07:00 AM - 05:00 PM EDT Abstract 095 - Purkinje Neurons: Structural and Functional Changes in Alzheimer’s Disease
Jonas Kruse
07:00 AM - 05:00 PM EDT Abstract 096 - Association of Inflammatory Disorders with Degenerative Neuropathologies
Candace B. Borders, MD
07:00 AM - 05:00 PM EDT Abstract 097 - CSF biomarkers predict long term improvement after shunt surgery for Idiopathic Normal Pressure Hydrocephalus
Alexandria E. Lewis
07:00 AM - 05:00 PM EDT Abstract 098 - Swallowing function in a long-term survivor with Creutzfeldt-Jakob disease
Kenjiro Kunieda
Faculty Disclosures
Erin P. Foff, MD Dr. Foff has received personal compensation for serving as an employee of Acadia pharm. Dr. Foff has received stock or an ownership interest from Acadia pharmaceuticals.
Kirk R. Daffner, MD, FÂé¶¹´«Ã½Ó³»­ The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
No disclosure on file
John C. Morris, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
David S. Knopman, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Camilla Cividini, MSc Ms. Cividini has nothing to disclose.
Puja Agarwal, PhD, MBA Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Advocate Health. The institution of Dr. Agarwal has received research support from NIH/NIA.
Heather Ma, MD Ms. Ma has nothing to disclose.
Eddie Stage, Jr. Mr. Stage has nothing to disclose.
Costantino Iadecola, MD Dr. Iadecola has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Broadview Ventures.
Bappaditya Ray, MD Dr. Ray has nothing to disclose.
Murray Grossman, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Johanna S. Balas, BS Ms. Balas has nothing to disclose.
Zachary Miller, MD Dr. Miller has nothing to disclose.
Ekhlas Assaedi, MD Dr. Assaedi has nothing to disclose.
Marie Charmaine C. Sy, MD Marie Charmaine Sy has nothing to disclose.
Lucio Tremolizzo Lucio Tremolizzo has nothing to disclose.
Yuichi Hayashi Yuichi Hayashi has nothing to disclose.
Spyridon Chalkias, MD Dr. Chalkias has received personal compensation for serving as an employee of Biogen.
David Irwin, MD The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.
Marilyn Albert Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Chair with Global Council on Brain Health.
Heather Katzen, PhD Dr. Katzen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Adult Hydrocephalus Clinical Research Network. Dr. Katzen has received publishing royalties from a publication relating to health care.
Angelia Kirkpatrick Angelia Kirkpatrick has nothing to disclose.
David Perry, MD The institution of Dr. Perry has received research support from NIH/NIA.
Shau Yu Lynch Shau Yu Lynch has received personal compensation for serving as an employee of AbbVie. Shau Yu Lynch has received personal compensation for serving as an employee of Eisai. Shau Yu Lynch has stock in AbbVie.
Belen Pascual, PhD The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
Aakash S. Shetty, MD Dr. Shetty has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Shetty has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Parkinson Canada.
Sara Van Mossevelde The institution of Ms. Van Mossevelde has received research support from King Baudouin Foundation - Fund Mr and Ms Deelen-Hollanders.
Martin Rabe, MSc Martin Rabe, M.Sc. has received personal compensation for serving as an employee of Eisai Inc.
Jessica Zwerling, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Zwerling has nothing to disclose.
Michela Leocadi, MSc Dr. Leocadi has nothing to disclose.
David A. Wolk, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care.
Micaela R. Owens, DO Dr. Owens has nothing to disclose.
Cyrus A. Raji, MD, PhD Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainreader ApS. Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apollo Health . Prof. Raji has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neurevolution Medicine.
Paul Ardayfio Paul Ardayfio has received personal compensation for serving as an employee of Eli Lilly and Co.. Paul Ardayfio has stock in Eli Lilly and Co.
Evelyn Lazar, MD Dr. Lazar has nothing to disclose.
Anitha Rao, MD An immediate family member of Dr. Rao has received personal compensation for serving as an employee of Abbvie. Dr. Rao has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurovision. Dr. Rao has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Virtusense. Dr. Rao has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. An immediate family member of Dr. Rao has stock in Abbvie. Dr. Rao has a non-compensated relationship as a Executive Board of Directors with Lewy Body Dementia Association that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Allison Snyder, MD Dr. Snyder has nothing to disclose.
Chantale O. Branson, MD, MSCR, FÂé¶¹´«Ã½Ó³»­ Dr. Branson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Branson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Paula Daunt, PhD Dr. Daunt has received personal compensation for serving as an employee of Cytox Ltd.
George Dale George Dale has nothing to disclose.
Katie Harrison Katie Harrison has received personal compensation for serving as an employee of Biogen. Katie Harrison has received stock or an ownership interest from Biogen.
Rezaul Khandker Rezaul Khandker has received personal compensation for serving as an employee of Merck & Co., Inc.. Rezaul Khandker has stock in Merck & Co., Inc..
Samuel N. Lockhart, PhD The institution of Dr. Lockhart has received research support from NIH.
Ma YIHONG, PhD Ms. YIHONG has nothing to disclose.
Edmond Teng, MD, PhD Dr. Teng has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Teng has received personal compensation for serving as an employee of Evidation Health. Dr. Teng has stock in F. Hoffman-La Roche. An immediate family member of Dr. Teng has stock in Evidation Health. Dr. Teng has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Teng has received intellectual property interests from a discovery or technology relating to health care.
Edoardo G. Spinelli, MD Dr. Spinelli has nothing to disclose.
Cynthia Correll, MD Dr. Correll has nothing to disclose.
Sharon S. Simon No disclosure on file
Leslie M. Shaw, PhD Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Shaw has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Shaw has received research support from NIA. The institution of Dr. Shaw has received research support from MJ Fox foundation for Parkinsons Research.
Guy A. Rouleau, MD, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Sandra Weintraub, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. Weintraub has nothing to disclose.
Alison Searle Alison Searle has received personal compensation for serving as an employee of Roche Products Ltd. Alison Searle has received stock or an ownership interest from Roche Holding AG.
Winston Chiong, MD The institution of Dr. Chiong has received research support from the National Institutes of Health. The institution of Dr. Chiong has received research support from the Dana Foundation. Dr. Chiong has received personal compensation in the range of $500-$4,999 for serving as a member, NeuroEthics Working Group with National Institutes of Health.
Marjorie Miraldo No disclosure on file
Dina S. Dass, MD Dr. Dass has nothing to disclose.
Tim Van Langenhove, MD, PhD Dr. Van Langenhove has nothing to disclose.
John R. Sims, MD Dr. Sims has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sims has stock in Eli Lilly and Company.
Ihtsham Haq, MD, FÂé¶¹´«Ã½Ó³»­ The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Adam Staffaroni Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aviado Bio. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CervoMed. Adam Staffaroni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Prevail Therepeutics/Eli Lilly. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Adam Staffaroni has received research support from NIH. The institution of Adam Staffaroni has received research support from Bluefield Project To Cure FTD. The institution of Adam Staffaroni has received research support from AFTD/ALSA. Adam Staffaroni has received personal compensation in the range of $500-$4,999 for serving as a Scientific Advisory Board member with AADF.
Carmen Castrillo-Viguera Dr. Castrillo-Viguera has received personal compensation for serving as an employee of Biogen. Dr. Castrillo-Viguera has received stock or an ownership interest from Biogen.
Paola Caroppo Paola Caroppo has nothing to disclose.
Ali Ezzati, MD The institution of Dr. Ezzati has received research support from NIA. The institution of Dr. Ezzati has received research support from Alzheimer's Association. The institution of Dr. Ezzati has received research support from Cure Alzheimer's Fund.
Ari Green, MD Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from NIH. The institution of Dr. Green has received research support from NIH / NINDS. The institution of Dr. Green has received research support from NIH / NINDS. Dr. Green has received intellectual property interests from a discovery or technology relating to health care.
Anthony Chukwunonso Ogbuehi, MSc Mr. Ogbuehi has nothing to disclose.
Joseph C. Masdeu, MD, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Ian Walker, MD Dr. Walker has nothing to disclose.
Makoto Ishii, MD, PhD Dr. Ishii has stock in Regeneron Pharmaceuticals. The institution of Dr. Ishii has received research support from NIH. The institution of Dr. Ishii has received research support from BrightFocus Foundation. The institution of Dr. Ishii has received research support from Alzheimer's Association. Dr. Ishii has received personal compensation in the range of $0-$499 for serving as a Author/Contributor with Relias Media.
Adam L. Boxer, MD, PhD An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care.
Akarin Hiransuthikul, MD Dr. Hiransuthikul has nothing to disclose.
Ziv Gan-Or, MD, PhD Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Gan-Or has received personal compensation in the range of $0-$499 for serving as a Consultant for Lighthouse. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Handl Therapeutics. Dr. Gan-Or has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial Biotech.
Mariel Rubin-Norowitz Mariel Rubin-Norowitz has nothing to disclose.
Bradley W. McEvoy Bradley W. McEvoy has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Bradley W. McEvoy has received stock or an ownership interest from Acadia Pharmaceuticals.
Sonja W. Scholz, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. An immediate family member of Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. The institution of Dr. Scholz has received research support from National Institutes of Health. The institution of an immediate family member of Dr. Scholz has received research support from National Institutes of Health. An immediate family member of Dr. Scholz has received intellectual property interests from a discovery or technology relating to health care. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Council Member with Lewy Body Dementia Association that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with JAMA Neurology that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with Journal of Parkinson's Disease that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with Mission MSA that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with The GBA1 Canada Initiative (G-Can) that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Anne Sieben, MD Dr. Sieben has nothing to disclose.
Elizabeth Finger, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali Therapeutics. The institution of Dr. Finger has received research support from CIHR. The institution of Dr. Finger has received research support from Physician Servcices Incorporated. The institution of Dr. Finger has received research support from Weston Foundation. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Annual Meeting Course Director with Âé¶¹´«Ã½Ó³»­.
Douglas W. Scharre, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Scharre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BrainTest, Inc. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Scharre has received research support from InSightec. The institution of Dr. Scharre has received research support from Alzheimer's Therapeutic Research Institute (ATRI). The institution of Dr. Scharre has received research support from Eisai. The institution of Dr. Scharre has received research support from vTv Therapeutics. The institution of Dr. Scharre has received research support from National Institute of Health. The institution of Dr. Scharre has received research support from Eli Lilly. The institution of Dr. Scharre has received research support from Biogen. The institution of Dr. Scharre has received research support from Roche. The institution of Dr. Scharre has received research support from Percision Medicine. The institution of Dr. Scharre has received research support from Premier Research Group. The institution of Dr. Scharre has received research support from Genetch. The institution of Dr. Scharre has received research support from Avanir. The institution of Dr. Scharre has received research support from Cerevel Therapeutics. The institution of Dr. Scharre has received research support from Janssen. The institution of Dr. Scharre has received research support from Cassava. The institution of Dr. Scharre has received research support from UniQure. The institution of Dr. Scharre has received research support from Cognition Therapeutics. The institution of Dr. Scharre has received research support from Cognitive Research Corporation. The institution of Dr. Scharre has received research support from EIP. The institution of Dr. Scharre has received research support from Cognito. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care.
Christian Bocti, MD Dr. Bocti has nothing to disclose.
Shuang Wu No disclosure on file
Carson Finger Carson Finger has nothing to disclose.
David P. Salmon, PhD Dr. Salmon has nothing to disclose.
Paige E. Logan Ms. Logan has nothing to disclose.
Michael Terranova Michael Terranova has nothing to disclose.
Kjell Svensson Kjell Svensson has received personal compensation for serving as an employee of Eli Lilly.
Gandis G. Mazeika, MD Dr. Mazeika has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Mazeika has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Brain Injury Law of Seattle. Dr. Mazeika has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Edward K. Le Attorney.
William W. Seeley, MD Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics. The institution of Dr. Seeley has received research support from NIH. The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation. The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD. The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative.
Laura Gutierrez Quiceno, MD Dr. Gutierrez Quiceno has nothing to disclose.
Daniel Levendowski Daniel Levendowski has received personal compensation for serving as an employee of Advanced Brain Monitoring, Inc.. Daniel Levendowski has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Advanced Brain Monitoring, Inc. Daniel Levendowski has received stock or an ownership interest from Advanced Brain Monitoring, Inc. The institution of Daniel Levendowski has received research support from National Institute of Health . Daniel Levendowski has received intellectual property interests from a discovery or technology relating to health care.
Massimo Filippi, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Bob Bucelli, MD, PhD Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bucelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Bucelli has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hamilton Weber. Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for O'Bryan Brown and Toner. Dr. Bucelli has stock in Neuroquestions.com. An immediate family member of Dr. Bucelli has stock in Neuroquestions.com. The institution of Dr. Bucelli has received research support from Biogen. The institution of Dr. Bucelli has received research support from Ionis.
Rebecca F. Gottesman, MD, PhD The institution of Dr. Gottesman has received research support from NIH.
Xi Richard Chen Mr. Chen has nothing to disclose.
Michael G. Erkkinen, MD Dr. Erkkinen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen.
Sharon Lam Sharon Lam has nothing to disclose.
Salvatore Spina, MD Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Techspert.io. Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lumanity. Dr. Spina has received research support from Tau Consortium. Dr. Spina has received research support from Chan Zuckerberg Initiative, LLC. Dr. Spina has received research support from Bluefield Project to Cure FTD. Dr. Spina has received research support from NIH. Dr. Spina has received research support from Larry L. Hillblom Foundation. Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Peking Union Medical Center Hospital.
Alexandria E. Lewis Alexandria Lewis has nothing to disclose.
Daven Crossland No disclosure on file
Simon Duchesne, PhD Dr. Duchesne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Qynapse SAS. Dr. Duchesne has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Group. Dr. Duchesne has received stock or an ownership interest from Qynapse SAS. Dr. Duchesne has received intellectual property interests from a discovery or technology relating to health care.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Christopher Wright Christopher Wright has received personal compensation for serving as an employee of Cyclerion. Christopher Wright has received personal compensation for serving as an employee of AavantiBio. Christopher Wright has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cyclerion. Christopher Wright has received stock or an ownership interest from Cyclerion. Christopher Wright has received stock or an ownership interest from AavantiBio. The institution of Christopher Wright has received research support from Alzheimer's Association.
Nabila Dahodwala, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Cindy Nowinski, MD PhD The institution of Dr. Nowinski has received research support from National Institutes of Health.
Amanda L. Porter, MD Dr. Porter has nothing to disclose.
Bernard J. Hanseeuw, MD, PhD Dr. Hanseeuw has nothing to disclose.
Daniel Bennett No disclosure on file
Andrzej Sokolowski Andrzej Sokolowski has nothing to disclose.
Lynn D. Kramer, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Kramer has received personal compensation for serving as an employee of Eisai Inc. Dr. Kramer has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Eisai Co., Ltd..
Michelle Anlacan Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as a Consultant for Torrent Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medichem Philippines. Michelle Anlacan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hi Eisai Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natrapharm Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's disease association of the philippines. Michelle Anlacan has received research support from Philippine Council for Health Research and Development. Michelle Anlacan has received research support from Philippine Neurological Association.
Rani A. Sarkis, MD, MSc The institution of Dr. Sarkis has received research support from NINDS.
Anne E. Hiniker, MD Dr. Hiniker has nothing to disclose.
Georgina Torrandell Haro Miss Torrandell Haro has nothing to disclose.
Veronica Castelnovo, MSc Dr. Castelnovo has nothing to disclose.
Larsson Omberg Larsson Omberg has nothing to disclose.
Fanny M. Elahi, MD, PhD Dr. Elahi has nothing to disclose.
Candace B. Borders, MD Dr. Borders has nothing to disclose.
Julie A. Fields, PhD The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute.
Scott Przybelski Scott Przybelski has nothing to disclose.
Hannah H. Nguyen, BS Hannah Nguyen has received research support from National Institutes of Health (NIH).
Beth Ann Haynes, MD Dr. Haynes has received personal compensation for serving as an employee of Alector, Inc..
Gregory S. Day, MD, MSc, FÂé¶¹´«Ã½Ó³»­ Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with Âé¶¹´«Ã½Ó³»­. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Âé¶¹´«Ã½Ó³»­, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Âé¶¹´«Ã½Ó³»­al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Paulo Bertolucci No disclosure on file
Jan L. De Bleecker, MD, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgNX. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. De Bleecker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. De Bleecker has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen pharmaceuticals. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. De Bleecker has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro.
Mark A. Mintun, MD Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co.
Daniel Weintraub Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Jiong Shi, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Shi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Neelum T. Aggarwal, MD Dr. Aggarwal has nothing to disclose.
Yushan Pan Ms. Pan has nothing to disclose.
Jane S. Paulsen, PhD Dr. Paulsen has received personal compensation in the range of $0-$499 for serving as a Consultant for CHDI. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Paulsen has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for HDSA. The institution of Dr. Paulsen has received research support from NIH/NIA. The institution of Dr. Paulsen has received research support from NIH/NINDS.
Sudha Seshadri, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Thomas M. McNally Mr. McNally has nothing to disclose.
Radhika Jagannathan, MD Dr. Jagannathan has nothing to disclose.
Erik K. St. Louis, MD The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Faheem Arshad, Sr., MD Dr. Arshad has nothing to disclose.
Kyra Neylan, MD Kyra Neylan has nothing to disclose.
Kevin M. Biglan, MD Dr. Biglan has received personal compensation for serving as an employee of Eli Lilly. Dr. Biglan has received stock or an ownership interest from Eli Lilly.
Samira Jamalian Samira JAMALIAN has received personal compensation for serving as an employee of GENENTECH. Samira JAMALIAN has received stock or an ownership interest from Genentech.
Louis-Charles Perrier-Ferland, MD Louis-Charles Perrier-Ferland has nothing to disclose.
Gad Marshall, MD Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma USA Inc. Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beth Israel Deaconness Medical Center. Dr. Marshall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Harvard Health Publications.
Michael Ward Michael Ward has received personal compensation for serving as an employee of Alector. Michael Ward has stock in Alector. Michael Ward has received intellectual property interests from a discovery or technology relating to health care. Michael Ward has a non-compensated relationship as a Reviewer with ADDF that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Elisabeth Hendrickx Van de Craen, MD Dr. Hendrickx Van de Craen has nothing to disclose.
Christian C. Prusinski, DO Dr. Prusinski has nothing to disclose.
Richard B. Lipton, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Ross Reichard Ross Reichard has nothing to disclose.
Takayoshi Shimohata, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Shimohata has nothing to disclose.
Zaina Qureshi Zaina Qureshi has received personal compensation for serving as an employee of Merck.
Gregory L. Branigan, PhD Dr. Branigan has nothing to disclose.
Samantha K. Holden, MD, MS, FÂé¶¹´«Ã½Ó³»­ The institution of Dr. Holden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics.
Peter P. De Deyn, MD, PhD Dr. De Deyn has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier.
James F. Morley, MD, PhD Dr. Morley has nothing to disclose.
James A. Mastrianni, MD, PhD Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS Caremark. Dr. Mastrianni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Mastrianni has received research support from Brain Research Foundation.
Giuseppe Magnani Giuseppe Magnani has nothing to disclose.
Chad E Glasser, PharmD Mr. Glasser has received personal compensation for serving as an employee of Cyclerion Therapeutics. Inc. Mr. Glasser has stock in Cyclerion Therapeutics Inc.. Mr. Glasser has received intellectual property interests from a discovery or technology relating to health care.
Quentin Funk Quentin Funk has nothing to disclose.
Kellen Petersen No disclosure on file
Stella McCaughey, PhD Dr. McCaughey has received personal compensation for serving as an employee of Alector, Inc. Dr. McCaughey has received stock or an ownership interest from Alector, Inc.
Emily Eijansantos, MD Dr. Eijansantos has nothing to disclose.
Eduardo M. Zilli, MD Dr. Zilli has nothing to disclose.
Shubir Dutt Mr. Dutt has nothing to disclose.
Luis D. Medina, PhD The institution of Dr. Medina has received research support from National Institutes of Health. Dr. Medina has received personal compensation in the range of $500-$4,999 for serving as a Speaker with AbbVie. Dr. Medina has a non-compensated relationship as a Council Member with Alzheimer's Association that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Helena Gossye Mrs. Gossye has nothing to disclose.
Parichita Choudhury, MD The institution of Dr. Choudhury has received research support from Lewy Body Dementia Association. The institution of Dr. Choudhury has received research support from Arizona Alzheimer's Consortium.
Mark Luciano, MD, PhD No disclosure on file
Jayandra Himali Jayandra Himali has nothing to disclose.
Andrew J. Saykin, PsyD Dr. Saykin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Oncology. Dr. Saykin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature Publishing. The institution of Dr. Saykin has received research support from Eli Lilly/Avid Radiopharmaceuticals.
Min Jiangyong, MD No disclosure on file
Jan Malm, PhD No disclosure on file
Douglas Galasko, MD Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics.
Thomas Neylan The institution of Thomas Neylan has received research support from National Institutes of Aging.
Deborah E. Barnes, PhD, MPH The institution of Dr. Barnes has received research support from the National Institutes of Health, Department of Veterans Affairs, Department of Defense, Alzheimer's Association, and the California Department of Public Health.
Joseph E. Parisi, MD Dr. Parisi has nothing to disclose.
Achitpol Thongkam Mr. Thongkam has nothing to disclose.
Rachel Henson No disclosure on file
Michael Kurnellas Michael Kurnellas has received personal compensation for serving as an employee of Alector. Michael Kurnellas has received stock or an ownership interest from Alector. Michael Kurnellas has received intellectual property interests from a discovery or technology relating to health care.
Norman Mazer Norman Mazer has received personal compensation for serving as an employee of F. Hoffman La-Roche. Norman Mazer has received stock or an ownership interest from F. Hoffmann-LaRoche.
Alice Chen-Plotkin, MD Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care.
David Shprecher, DO, FÂé¶¹´«Ã½Ó³»­ Dr. Shprecher has received personal compensation for serving as an employee of Banner Health. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanders+Parks. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medplace. The institution of Dr. Shprecher has received research support from MJFF. The institution of Dr. Shprecher has received research support from Cognition Therapeutics. The institution of Dr. Shprecher has received research support from Biogen. The institution of Dr. Shprecher has received research support from Neuraly. The institution of Dr. Shprecher has received research support from Jazz Pharmaceuticals. The institution of Dr. Shprecher has received research support from Sanofi Aventis. The institution of Dr. Shprecher has received research support from Annovis. The institution of Dr. Shprecher has received research support from Neurocrine. The institution of Dr. Shprecher has received research support from Teva. The institution of Dr. Shprecher has received research support from Nuvelution. The institution of Dr. Shprecher has received research support from EIP Pharma. Dr. Shprecher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson's and MDS. Dr. Shprecher has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Parkinson's Movement Disorder Alliance.
Arjun V. Masurkar, MD The institution of Dr. Masurkar has received research support from NIH. The institution of Dr. Masurkar has received research support from Alzheimer's Association. The institution of Dr. Masurkar has received research support from BrightFocus Foundation. Dr. Masurkar has received personal compensation in the range of $500-$4,999 for serving as a IRGP Advisory Council Member with Alzheimer's Association. Dr. Masurkar has a non-compensated relationship as a Steering Committee Member with Alzheimer's Disease Cooperative Study that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Alexa Beiser Alexa Beiser has nothing to disclose.
Andrea Vincent Andrea Vincent has received personal compensation for serving as an employee of Vista LifeSciences. The institution of Andrea Vincent has received research support from Medical Technology Enterprise Consortium (MTEC).
Sebastiaan Engelborghs, MD, PhD No disclosure on file
Emily Trenholm No disclosure on file
Sanjeev Vaishnavi, MD, PhD The institution of Dr. Vaishnavi has received research support from Novartis.
Robert A. Sweet Robert A. Sweet has nothing to disclose.
Somayeh Meysami, MD Dr. Meysami has nothing to disclose.
Joel Salinas, MD, MBA, MSc, FÂé¶¹´«Ã½Ó³»­ Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai, Inc. Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly, Inc. Dr. Salinas has stock in Isaac Health.
Samantha Budd Haeberlein Samantha Budd Haeberlein has received personal compensation for serving as an employee of Biogen. An immediate family member of Samantha Budd Haeberlein has received personal compensation for serving as an employee of Alkermes. Samantha Budd Haeberlein has received stock or an ownership interest from Biogen.
Junxiang Yin, MD Dr. Yin has nothing to disclose.
Bruce L. Miller, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Miller has nothing to disclose.
Kejal Kantarci, MD The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Roberta Diaz Brinton, PhD Roberta Diaz Brinton, PhD has nothing to disclose.
Emilie Beaulieu, MD Émilie Beaulieu has nothing to disclose.
Christine M. Walsh, PhD Dr. Walsh has nothing to disclose.
Timothy M. Hughes No disclosure on file
Kee Duk Park, MD No disclosure on file
Zeynep Demir, MD Dr. Demir has nothing to disclose.
Jennifer Zitser-Koren, MD Dr. Zitser-Koren has nothing to disclose.
Michael C. Irizarry, MD Dr. Irizarry has received personal compensation for serving as an employee of Eisai, Inc..
Martin J. Sadowski, MD, PhD The institution of Dr. Sadowski has received research support from National Institute on Aging. The institution of Dr. Sadowski has received research support from Biogen. The institution of Dr. Sadowski has received research support from Novartis. The institution of Dr. Sadowski has received research support from Janssen Research and Development. The institution of Dr. Sadowski has received research support from Eisai. The institution of Dr. Sadowski has received research support from TauRx Therapeutics Ltd. The institution of Dr. Sadowski has received research support from Suven Life Sciences Ltd.. The institution of Dr. Sadowski has received research support from Merck Sharp & Dohme Corp.. The institution of Dr. Sadowski has received research support from Alzheimer's Disease Cooperative Study. The institution of Dr. Sadowski has received research support from Neurotrack Technologies Inc.. Dr. Sadowski has received intellectual property interests from a discovery or technology relating to health care. Dr. Sadowski has received personal compensation in the range of $100,000-$499,999 for serving as a VA Physician with Veterans' Affairs.
Joanne M. Hamilton The institution of an immediate family member of Ms. Hamilton has received research support from Department of Veterans Affairs.
Leah K. Forsberg, PhD Ms. Forsberg has nothing to disclose.
Shivany Condor Montes No disclosure on file
Jagan Pillai, MD, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Nature. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. The institution of Dr. Pillai has received research support from Alzheimer's Association. The institution of Dr. Pillai has received research support from Keep Memory Alive Foundation . The institution of Dr. Pillai has received research support from NIA. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with DOD. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with RGC Hong kong.
Peihao Fan, MBBS Mr. Fan has nothing to disclose.
Jim Scott No disclosure on file
Ece Bayram, MD, PhD The institution of Dr. Bayram has received research support from National Institute on Aging (K99AG073453). The institution of Dr. Bayram has received research support from Lewy Body Dementia Association. The institution of Dr. Bayram has received research support from National Institute of Neurological Disorders and Stroke.
Abhay Moghekar, MD Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Deluca and Weizenbaum. Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Silver Golub and Tieteel. The institution of Dr. Moghekar has received research support from NIH. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Hydrocephalus Association that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Spinal CSF Leak Foundation that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
David H. Salat David H. Salat has or had stock in Niji.David H. Salat has or had stock in Smart Ion. The institution of David H. Salat has received research support from Renew.
Chad J. Swanson Chad J Swanson has received personal compensation for serving as an employee of Eisai Inc..
Francesca Caso, MD Dr. Caso has nothing to disclose.
Anthony S. Basile, PhD Dr. Basile has received personal compensation for serving as an employee of Merck Research Labs. Dr. Basile has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Above and Beyond Research. Dr. Basile has received stock or an ownership interest from Merck Research Labs. Dr. Basile has received intellectual property interests from a discovery or technology relating to health care.
Julie Van Der Zee No disclosure on file
Casey Nicastri Casey Nicastri has nothing to disclose.
Alan Plotzker, MD Dr. Plotzker has nothing to disclose.
David G. Coughlin, MD Dr. Coughlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. The institution of Dr. Coughlin has received research support from Âé¶¹´«Ã½Ó³»­. The institution of Dr. Coughlin has received research support from NIA. The institution of Dr. Coughlin has received research support from NINDS.
David T. Jones, MD Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.
Silvia Basaia Silvia Basaia has nothing to disclose.
Mark Hamilton, MD Dr. Hamilton has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Integra International. Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Hamilton has received research support from Hydrocephalus Association. The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Alberta Innovates.
Virginia Sturm, PhD Dr. Sturm has nothing to disclose.
Melissa Murray, PhD Dr. Murray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avid Radiopharmaceuticals. The institution of Dr. Murray has received research support from National Institute on Aging. The institution of Dr. Murray has received research support from Alzheimer's Association. The institution of Dr. Murray has received research support from Chan Zuckerberg Initiative.
Ashlyn G. Johnson The institution of Ms. Johnson has received research support from BrightFocus Foundation.
Rodolfo Savica, MD, PhD, FÂé¶¹´«Ã½Ó³»­ The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
James R. Bateman III, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Bateman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerView CME. Dr. Bateman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EfficientCME. The institution of Dr. Bateman has received research support from NIA. The institution of Dr. Bateman has received research support from Dementia Alliance of North Carolina. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Drug Discovery Foundation. Dr. Bateman has a non-compensated relationship as a Committee Member with UCNS that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Oksana Suchowersky, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Bradley F. Boeve, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Gregory Klein, PhD Dr. Klein has received personal compensation for serving as an employee of Roche. Dr. Klein has received stock or an ownership interest from Roche.
Jason A. Cohen, MD Dr. Cohen has nothing to disclose.
Kenjiro Kunieda Kenjiro Kunieda has nothing to disclose.
Palak S. Patel, MD Dr. Patel has nothing to disclose.
Theresa Driscoll No disclosure on file
Clive G. Ballard, MD Clive G. Ballard, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Clive G. Ballard, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Clive G. Ballard, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Clive G. Ballard, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AARP. Clive G. Ballard, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Addex. Clive G. Ballard, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Clive G. Ballard, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Excivia. Clive G. Ballard, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for E Lilly.
Katherine P. Rankin, PhD The institution of Dr. Rankin has received research support from Marcus Foundation.
Sue Hyun Lee The institution of Sue Hyun Lee has received research support from Basic Science Research Program through the National Research Foundation of Korea(NRF).
Harald Hampel Harald Hampel has received personal compensation for serving as an employee of Eisai Inc..
Joe Verghese, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Verghese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms Inc. The institution of Dr. Verghese has received research support from National Institutes of Health.
Kristine Yaffe, MD Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Pierre Tariot Pierre Tariot has received personal compensation for serving as an employee of Banner Alzheimer's Institute. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WebMD. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcadia. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioXcel. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNOVA. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Pierre Tariot has received intellectual property interests from a discovery or technology relating to health care.
Nicole Vrettos Ms. Vrettos has nothing to disclose.
Michael D. Geschwind, MD, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Emer McGrath, MB, BCh, PhD Dr. McGrath has nothing to disclose.
Jeremiah Aakre, MPH Mr. Aakre has nothing to disclose.
Jean-Luc Rolland, MD Mr. Rolland has nothing to disclose.
Anna E. Blanken Ms. Blanken has nothing to disclose.
Ronald C. Petersen, MD, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Mario F. Mendez, MD, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Âé¶¹´«Ã½Ó³»­ Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Judith Aharon-Peretz, MD Dr. Aharon-Peretz has nothing to disclose.
Patrick Cras, MD, PhD The institution of Dr. Cras has received research support from Belgian Fund for Scientific Research. Dr. Cras has received personal compensation in the range of $0-$499 for serving as a member with National Bioethics Committee.
Mallika Purandare Mallika Purandare has nothing to disclose.
Irene Litvan, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology.
Claudia L. Satizabal, PhD The institution of Dr. Satizabal has received research support from NIH and TARCC.
Daniel A. Nation, PhD Dr. Nation has nothing to disclose.
Suvarna Alladi, Sr., MD Dr. Alladi has nothing to disclose.
Vibhor Krishna No disclosure on file
Michael A. Williams, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Williams has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for the Hydrocephalus Association, a not-for-profit patient advocacay organization. The institution of Dr. Williams has received research support from NASA. The institution of Dr. Williams has received research support from Translational Research Insitute for Space Health (TRISH). The institution of Dr. Williams has received research support from NINDS.
Donna Tran Miss Tran has received research support from The Medical Student Training in Aging Research Program UCSF and National Institute of Aging.
Adrienne O'Donnell No disclosure on file
Tanya Bogoslovsky, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Bogoslovsky has received personal compensation for serving as an employee of Eisai Inc.
Liana Apostolova, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for siemens. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. Dr. Apostolova has a non-compensated relationship as a advisor with FDA that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Juneyoung Lee, PhD Juneyoung Lee, PhD has nothing to disclose.
Calin I. Prodan, MD The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
Frederike Cosima Oertel, MD The institution of Dr. Oertel has received research support from Âé¶¹´«Ã½Ó³»­. The institution of Dr. Oertel has received research support from Hertie Foundation. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ECTRIMS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with NMSS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ACTRIMS.
Aimen Vanood, MD Dr. Vanood has nothing to disclose.
Jumana T. Alshaikh, MD Dr. Alshaikh has nothing to disclose.
Vincenzo Silani, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Silani has nothing to disclose.
Belinda Yew Ms. Yew has nothing to disclose.
Larisa Reyderman Larisa Reyderman has nothing to disclose.
Gabriela T. Gomez Ms. Gomez has nothing to disclose.
Eleanor Palser, PhD Eleanor Palser has nothing to disclose.
Robert Paul, MD, PhD Dr. Paul has received personal compensation for serving as an employee of Alector. Dr. Paul has received stock or an ownership interest from Alector.
Leanne Munsie Leanne Munsie has received personal compensation for serving as an employee of Eli Lilly and Company. Leanne Munsie has received stock or an ownership interest from Eli Lilly and Company.
Justin Y. Kwan, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Kwan has received research support from National Institutes of Health. Dr. Kwan has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with National Institutes of Health.
Otto Pedraza The institution of Otto Pedraza has received research support from Alzheimer's Association. Otto Pedraza has received publishing royalties from a publication relating to health care.
James M. Youakim, MD Dr. Youakim has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Youakim has stock in Acadia Pharmaceuticals.
Sandro Almeida No disclosure on file
Carolina R. Silveira, PhD Carolina Silveira has nothing to disclose.
Katherine L. Possin, PhD Dr. Possin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ClearView Healthcare Partners. The institution of Dr. Possin has received research support from Quest Diagnostics. The institution of Dr. Possin has received research support from NIH. The institution of Dr. Possin has received research support from The Global Brain Health Institute. The institution of Dr. Possin has received research support from The Rainwater Foundation.
David N. Soleimani-Meigooni, MD Dr. Soleimani-Meigooni has nothing to disclose.
Jonathan Graff-Radford, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
Tanis J. Ferman, PhD Ms. Ferman has nothing to disclose.
Bharti Manwani, MD Dr. Manwani has nothing to disclose.
Laurel J. Cherian, MD, FÂé¶¹´«Ã½Ó³»­ The institution of Dr. Cherian has received research support from NIH.
Takahisa Mikami, MD Dr. Mikami has nothing to disclose.
Laura Allen, NP Ms. Allen has nothing to disclose.
Toji Miyagawa, MD, PhD Dr. Miyagawa has nothing to disclose.
Howard J. Rosen, MD Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly . Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alector. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
S. Ahmad Sajjadi, MD, PhD, MRCP, FÂé¶¹´«Ã½Ó³»­ Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GUIDEPOINT. Dr. Sajjadi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Research and Therapy. The institution of Dr. Sajjadi has received research support from NIH.
Debby W. Tsuang, MD Dr. Tsuang has nothing to disclose.
Alice Tao Ms. Tao has nothing to disclose.
Chad Hales, MD, PhD, FÂé¶¹´«Ã½Ó³»­ The institution of Dr. Hales has received research support from BrightFocus foundation. The institution of Dr. Hales has received research support from NIH. The institution of Dr. Hales has received research support from State of Georgia. Dr. Hales has a non-compensated relationship as a committee member with Âé¶¹´«Ã½Ó³»­ that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Christopher T. Whitlow, MD Dr. Whitlow has nothing to disclose.
Fabricio F. De Oliveira, MD, PhD, BBA, MSc, FÂé¶¹´«Ã½Ó³»­ Dr. De Oliveira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gerson Lehrman Group. Dr. De Oliveira has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Atheneum Partners. Dr. De Oliveira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. De Oliveira has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lionbridge. Dr. De Oliveira has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman. Dr. De Oliveira has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. De Oliveira has received personal compensation in the range of $0-$499 for serving as a Neurology® Video Journal Club Presenter with Âé¶¹´«Ã½Ó³»­.
Roland Dominic Jamora Roland Dominic Jamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for torrent. Roland Dominic Jamora has received research support from CCXDP.
Dixon Yang, MD Dr. Yang has nothing to disclose.
Michael Levy, MD, PhD, FÂé¶¹´«Ã½Ó³»­ Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Neill R. Graff-Radford, MD, FÂé¶¹´«Ã½Ó³»­ The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Lea Grinberg Lea Grinberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Inc. The institution of Lea Grinberg has received research support from NIH. The institution of Lea Grinberg has received research support from Eli Lilly. The institution of Lea Grinberg has received research support from BrightFouus. The institution of Lea Grinberg has received research support from Rainwater Charity Foundation.
Tara Carlisle, MD, PhD The institution of Dr. Carlisle has received research support from University of Colorado Denver | Anschutz Medical Campus - NIH Gap Funding. The institution of Dr. Carlisle has received research support from Interdepartmental Alzheimer's Disease Clinical Care and Research Award | Maria Teresa Jones Alzheimer's Disease Fund. The institution of Dr. Carlisle has received research support from NIH/NIA R01AG071151 (PI: Potter). The institution of Dr. Carlisle has received research support from Anschutz Acceleration Initiative Research Grant (PI: Matlock/Glasgow). Dr. Carlisle has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ADRD Research Âé¶¹´«Ã½Ó³»­ and Appreciation Event. Dr. Carlisle has a non-compensated relationship as a Invited Speaker with Parkinson Association of the Rockies that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Carlisle has a non-compensated relationship as a Invited Speaker with Women in Neurology Group that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Carlisle has a non-compensated relationship as a Invited Speaker with Âé¶¹´«Ã½Ó³»­ that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Carlisle has a non-compensated relationship as a Invited Speaker with American Neuropsychiatry Association that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Carlisle has a non-compensated relationship as a Ad hoc Reviewer with The Journal of Neuropsychiatry and Clinical Neurosciences that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Carlisle has a non-compensated relationship as a Ad hoc Reviewer with Frontiers in Neuroscience, Neurodegeneration Section that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Carlisle has a non-compensated relationship as a Speaker with Alzheimer's Association that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Carlisle has a non-compensated relationship as a Expert for Media Reports with UCHealth Today that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Carlisle has a non-compensated relationship as a Expert for Media Reports with Rocky Mountain PBS that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Carlisle has a non-compensated relationship as a Expert for Media Reports with Neurology Today that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Val J. Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Christine Van Broeckhoven, PhD Dr. Van Broeckhoven has nothing to disclose.
James B. Leverenz, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Jonas Kruse Mr. Kruse has nothing to disclose.
Farid Chekani, PhD Mr. Chekani has received personal compensation for serving as an employee of Merck & Co., Inc..
Saptaparni Ghosh No disclosure on file
Caroline Dallaire-Théroux, MD, PhD Dr. Dallaire-Théroux has received research support from Canadian Institutes of Health Research (CIHR).
Joyce K. Lee-Iannotti, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Lee-Iannotti has nothing to disclose.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Page B. Pennell, MD, FÂé¶¹´«Ã½Ó³»­ The institution of Dr. Pennell has received research support from NIH.
Sarah Pila Sarah Pila has nothing to disclose.
Min Young Chun, MD Dr. Chun has nothing to disclose.
Gil D. Rabinovici, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with Âé¶¹´«Ã½Ó³»­. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
Emily Hardy Emily Hardy has nothing to disclose.
Noam Margalit Noam Margalit has nothing to disclose.
Shobha Dhadda Shobha Dhadda has received personal compensation for serving as an employee of Eisai Inc.
John Q. Trojanowski, MD, PhD Dr. Trojanowski has nothing to disclose.
Walter Kremers The institution of Walter Kremers has received research support from NIH. The institution of an immediate family member of Walter Kremers has received research support from NIH.
John E. Duda, MD Dr. Duda has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Publishing Group. The institution of Dr. Duda has received research support from Department of Veterans Affairs. The institution of Dr. Duda has received research support from Michael J. Fox Foundation. The institution of Dr. Duda has received research support from Innervace, Incorporated. The institution of Dr. Duda has received research support from National Institutes of Health.
Samir Datta Mr. Datta has nothing to disclose.
Gloria Chiang Gloria Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Life Molecular Imaging. Gloria Chiang has received personal compensation in the range of $0-$499 for serving as a Consultant for Alnylam. The institution of Gloria Chiang has received research support from Minoryx Therapeutics. The institution of Gloria Chiang has received research support from National Institutes of Health. Gloria Chiang has received personal compensation in the range of $5,000-$9,999 for serving as a speaker with Efficient CME. Gloria Chiang has received personal compensation in the range of $500-$4,999 for serving as a speaker with PeerView.
Andrew D. Siderowf, MD Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Aaron Kaat Aaron Kaat has received personal compensation for serving as an employee of Northwestern University. Aaron Kaat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kaat Psychometric and Statistic Consulting.
Timothy Lesnick No disclosure on file
Kyan Younes, MD Dr. Younes has nothing to disclose.
Rian L. Bogley Mr. Bogley has nothing to disclose.
Hugo Javier Aparicio, MD, MPH Dr. Aparicio has received research support from Âé¶¹´«Ã½Ó³»­. Dr. Aparicio has received research support from Alzheimer's Association. Dr. Aparicio has received research support from National Institutes of Health. Dr. Aparicio has received personal compensation in the range of $10,000-$49,999 for serving as a expert panelist for the Memory & Healthy Aging Program with Cedars-Sinai.
Shannon Risacher Shannon Risacher has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Shannon Risacher has stock in Eli Lilly. Shannon Risacher has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH.
Jeremy Tanner, MD An immediate family member of Dr. Tanner has received personal compensation for serving as an employee of Channeling Hope Foundation. The institution of Dr. Tanner has received research support from NIA, NINDS. Dr. Tanner has a non-compensated relationship as a Chief Scientific Officer with Channeling Hope Foundation that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Erica McKenzie, MD Dr. McKenzie has nothing to disclose.
James R. Nelson, MD, FÂé¶¹´«Ã½Ó³»­ No disclosure on file
Maria Naffah-Mazzacoratti No disclosure on file
Sergio A. Ramirez-Salazar, MD Dr. Ramirez-Salazar has nothing to disclose.
Meixiang Yu No disclosure on file
Jee H. Jeong, MD Dr. Jeong has nothing to disclose.
Martin Traber Martin Traber has received personal compensation for serving as an employee of F. Hoffmann-LaRoche Inc.. Martin Traber has received stock or an ownership interest from F. Hoffmann-LaRoche Inc..
Geoffrey A. Kerchner, MD, PhD Dr. Kerchner has received personal compensation for serving as an employee of F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has stock in F. Hoffmann-La Roche, Ltd.. Dr. Kerchner has received publishing royalties from a publication relating to health care.
Eduardo Castro-Neto No disclosure on file
Ildebrando H. Appollonio, MD Dr. Appollonio has nothing to disclose.
Maria Luisa Gorno Tempini, MD, PhD The institution of Dr. Gorno Tempini has received research support from the NIH.
Paolo Zanotti Fregonara Paolo Zanotti Fregonara has nothing to disclose.
Neus Falgàs Martínez Neus Falgàs Martínez has nothing to disclose.